Cargando…

Novel monoclonal antibodies targeting the microtubule-binding domain of human tau

Tauopathies including Alzheimer’s disease and Progressive Supranuclear Palsy are a diverse group of progressive neurodegenerative disorders pathologically defined by inclusions containing aberrantly aggregated, post-translationally modified tau. The tau pathology burden correlates with neurodegenera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Croft, Cara L., Moore, Brenda D., Ran, Yong, Chakrabarty, Paramita, Levites, Yona, Golde, Todd E., Giasson, Benoit I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880389/ https://www.ncbi.nlm.nih.gov/pubmed/29608591 http://dx.doi.org/10.1371/journal.pone.0195211

Ejemplares similares

Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau
por: Strang, Kevin H., et al.
Publicado: (2017)

Designing antibodies against LRRK2-targeted tau epitopes
por: Hamm, Matthew, et al.
Publicado: (2018)

A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies
por: Dhillon, Jess-Karan S., et al.
Publicado: (2017)

Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation
por: Xia, Yuxing, et al.
Publicado: (2023)

Human tauopathy strains defined by phosphorylation in R1-R2 repeat domains of tau
por: Smith, Ethan D., et al.
Publicado: (2023)

An anti-CRF antibody suppresses the HPA axis and reverses stress-induced phenotypes
por: Futch, Hunter S., et al.
Publicado: (2019)

A C1qTNF3 collagen domain fusion chaperones diverse secreted proteins and anti-Aβ scFvs: Applications for gene therapies
por: Moore, Brenda D., et al.
Publicado: (2023)

rAAV-based brain slice culture models of Alzheimer’s and Parkinson’s disease inclusion pathologies
por: Croft, Cara L., et al.
Publicado: (2019)

Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice
por: Koller, Emily J., et al.
Publicado: (2017)

Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes
por: Goodwin, Marshall S., et al.
Publicado: (2021)

Differential cross-seeding properties of tau and α-synuclein in mouse models of tauopathy and synucleinopathy
por: Williams, Tosha, et al.
Publicado: (2020)

Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Aβ immunotherapy
por: Das, Pritam, et al.
Publicado: (2006)

Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains
por: Moore, Brenda D, et al.
Publicado: (2012)

Fyn depletion ameliorates tau(P301L)-induced neuropathology
por: Liu, Guanghao, et al.
Publicado: (2020)

Tau K321/K353 pseudoacetylation within KXGS motifs regulates tau–microtubule interactions and inhibits aggregation
por: Xia, Yuxing, et al.
Publicado: (2021)

Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity
por: Sorrentino, Zachary A., et al.
Publicado: (2017)

Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation
por: Li, Longfei, et al.
Publicado: (2022)

Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
por: Sacino, Amanda N, et al.
Publicado: (2013)

Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions
por: Croft, Cara L., et al.
Publicado: (2021)

Il-10 signaling reduces survival in mouse models of synucleinopathy
por: Cockey, Samuel G., et al.
Publicado: (2021)

Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice
por: Xia, Yuxing, et al.
Publicado: (2022)

Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis
por: Xu, Guilian, et al.
Publicado: (2020)

Tau mutation S356T in the three repeat isoform leads to microtubule dysfunction and promotes prion-like seeded aggregation
por: Xia, Yuxing, et al.
Publicado: (2023)

Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
por: Golde, Todd E, et al.
Publicado: (2013)

Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain
por: Chakrabarty, Paramita, et al.
Publicado: (2013)

Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members
por: Hwang, Andrew W., et al.
Publicado: (2016)

Microtubule-binding core of the tau protein
por: El Mammeri, Nadia, et al.
Publicado: (2022)

Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy
por: Clippinger, Amy K., et al.
Publicado: (2013)

Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity
por: Koller, Emily J., et al.
Publicado: (2020)

Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans
por: Weisová, Petronela, et al.
Publicado: (2019)

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
por: Xia, Yuxing, et al.
Publicado: (2020)

Astrocytic apoE4 and tau: Deadly combination for neurons
por: Chakrabarty, Paramita, et al.
Publicado: (2021)

Partial mimicry of the microtubule binding of tau by its membrane binding
por: MacAinsh, Matthew, et al.
Publicado: (2023)

Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
por: Dhillon, Jess-Karan S., et al.
Publicado: (2019)

Tau proteins: the molecular structure and mode of binding on microtubules
Publicado: (1988)

Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo
por: Chakrabarty, Paramita, et al.
Publicado: (2011)

Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau
Publicado: (1994)

The microtubule binding domain of microtubule-associated protein MAP1B contains a repeated sequence motif unrelated to that of MAP2 and tau
Publicado: (1989)

α-Synuclein Induces Progressive Changes in Brain Microstructure and Sensory-Evoked Brain Function That Precedes Locomotor Decline
por: Chu, Winston T., et al.
Publicado: (2020)

“Don’t Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer’s disease and other tauopathies
por: Xia, Yuxing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_thn70aijb8l6hfbdj4ust50u1d